Stay updated on Immunogenicity Safety of 13-valent Pneumococcal Vaccine Clinical Trial

Sign up to get notified when there's something new on the Immunogenicity Safety of 13-valent Pneumococcal Vaccine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenicity Safety of 13-valent Pneumococcal Vaccine Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T22:25:12.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine compared with 23-valent Pneumococcal Polysaccharide Vaccine in adults aged 50 years and older.
    Difference
    0.2%
    Check dated 2024-06-06T14:34:00.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying that healthy male and female adults over 50 years of age who understand the study requirements and consent to participate are eligible. Additionally, it now includes specific inclusion and exclusion criteria related to health conditions and prior treatments.
    Difference
    26%
    Check dated 2024-05-22T21:20:55.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:45:27.000Z thumbnail image

Stay in the know with updates to Immunogenicity Safety of 13-valent Pneumococcal Vaccine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenicity Safety of 13-valent Pneumococcal Vaccine Clinical Trial page.